Report
Iris Tan
EUR 101.80 For Business Accounts Only

We Increase FVE for PICC Group After Its P&C Business Delivered Strong 3Q Results

Following PICC P&C’s upbeat third-quarter announcement, we have increased our fair value estimate for PICC P&C to HKD 17.50 per share from HKD 16 per share, as we increase our premium growth assumption and fine-tune our underwriting margin assumption for the next two years. Accordingly, we increase our fair value estimate for PICC Group to HKD 4.30 from HKD 4 per share, as the group owns 69% of PICC P&C, which contributed 98% of profit before tax for the group in 2016. The firm's oth...
Underlying
People's Insurance Co. (Group) of China Ltd. Class H

People's Insurance Company of China, through more than 10 subsidiaries, is engaged in property and casualty insurance, life insurance, health insurance, asset management, insurance brokerage and trust, fund, insurance financial industry cluster and integrated business group structure for the public and agencies Group provides comprehensive insurance and financial services.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Iris Tan

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch